Literature DB >> 29452783

Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity.

Francesco Bellanti1, Antonino D Romano2, Aurelio Lo Buglio2, Valeria Castriotta3, Giuseppe Guglielmi4, Antonio Greco5, Gaetano Serviddio2, Gianluigi Vendemiale2.   

Abstract

OBJECTIVES: To define whether circulating markers of oxidative stress correlate with sarcopenia in terms of glutathione balance and oxidative protein damage, and whether these biomarkers are associated with risk of cardiovascular disease (CVD). STUDY
DESIGN: Population-based cross-sectional study. 115 out of 347 elderly subjects were classified as non-sarcopenic non-obese (NS-NO), sarcopenic non-obese (S-NO), non-sarcopenic obese (NS-O), and sarcopenic obese (S-O). MAIN OUTCOME MEASUREMENTS: Sarcopenia was defined as a relative skeletal muscle mass index (RASM) <7.25kg/m2 for men or <5.67kg/m2 for women, while obesity was diagnosed in those presenting with% fat >27 for men or >38 for women. The CVD risk was estimated by the carotid intima-media thickness (IMT) and the Framingham score. Blood reduced glutathione (GSH), oxidized glutathione (GSSG), plasma malondialdehyde-(MDA) and 4-hydroxy-2,3-nonenal-(HNE) protein adducts were analyzed.
RESULTS: Significantly greater blood GSSG/GSH ratio and plasma MDA/HNE protein adducts were observed in sarcopenic than in non-sarcopenic patients. A logistic regression model showed a close relationship between serum HNE and MDA adducts and sarcopenia (OR=1.133, 95% CI 1.057-1.215, and OR=1.592, 95% CI 1.015-1.991, respectively). Linear and logistic regression analysis evidenced strong associations between the IMT or the Framingham CVD risk category and blood GSSG/GSH or serum HNE protein adducts in the S-O group.
CONCLUSION: Circulating markers of oxidative stress are increased in sarcopenia and related to CVD risk in sarcopenic obesity, suggesting that redox balance analysis would be a useful part of a multidimensional evaluation in aging. Further research is encouraged to support interventional strategies to correct redox imbalance, which might contribute to the prevention or at least limitation of sarcopenia and its co-morbidities.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular risk; Glutathione; Oxidative stress; Sarcopenia

Mesh:

Substances:

Year:  2017        PMID: 29452783     DOI: 10.1016/j.maturitas.2017.12.002

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  36 in total

Review 1.  Sarcopenic obesity: research advances in pathogenesis and diagnostic criteria.

Authors:  Wen-Qing Xie; Ge-Lei Xiao; Yi-Bin Fan; Miao He; Shan Lv; Yu-Sheng Li
Journal:  Aging Clin Exp Res       Date:  2019-12-16       Impact factor: 3.636

Review 2.  Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.

Authors:  Benedict J Maliakkal
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

3.  Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity.

Authors:  Ah Young Leem; Young Sam Kim; Kung Soo Chung; Moo Suk Park; Young Ae Kang; Young-Mok Park; Ji Ye Jung
Journal:  Respir Res       Date:  2022-07-13

4.  Characteristics of P-Type and N-Type Photoelectrochemical Biosensors: A Case Study for Esophageal Cancer Detection.

Authors:  Joseph-Hang Leung; Hong-Thai Nguyen; Shih-Wei Feng; Sofya B Artemkina; Vladimir E Fedorov; Shang-Chin Hsieh; Hsiang-Chen Wang
Journal:  Nanomaterials (Basel)       Date:  2021-04-21       Impact factor: 5.076

5.  Grape Polyphenols Ameliorate Muscle Decline Reducing Oxidative Stress and Oxidative Damage in Aged Rats.

Authors:  Giuseppe Annunziata; Manuel Jimenez-García; Silvia Tejada; David Moranta; Angela Arnone; Roberto Ciampaglia; Gian Carlo Tenore; Antoni Sureda; Ettore Novellino; Xavier Capó
Journal:  Nutrients       Date:  2020-04-30       Impact factor: 5.717

6.  Sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer: results from the ABLE feasibility trial.

Authors:  Vincent Pialoux; Béatrice Fervers; Lidia Delrieu; Agnès Martin; Marina Touillaud; Olivia Pérol; Magali Morelle; Olivia Febvey-Combes; Damien Freyssenet; Christine Friedenreich; Armelle Dufresne; Thomas Bachelot; Pierre-Etienne Heudel; Olivier Trédan; Hugo Crochet; Amine Bouhamama; Frank Pilleul
Journal:  Breast Cancer Res Treat       Date:  2021-05-19       Impact factor: 4.872

Review 7.  Skeletal muscle (dys)function in heart failure with preserved ejection fraction.

Authors:  Eng Leng Saw; Swetha Ramachandran; Maria Valero-Muñoz; Flora Sam
Journal:  Curr Opin Cardiol       Date:  2021-03-01       Impact factor: 2.108

Review 8.  Molecular Aspects and Treatment of Iron Deficiency in the Elderly.

Authors:  Antonino Davide Romano; Annalisa Paglia; Francesco Bellanti; Rosanna Villani; Moris Sangineto; Gianluigi Vendemiale; Gaetano Serviddio
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

9.  Serum levels of protein carbonyl, a marker of oxidative stress, are associated with overhydration, sarcopenia and mortality in hemodialysis patients.

Authors:  Young Rim Song; Jwa-Kyung Kim; Hyung-Seok Lee; Sung Gyun Kim; Eun-Kyoung Choi
Journal:  BMC Nephrol       Date:  2020-07-16       Impact factor: 2.388

10.  Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients.

Authors:  Jessy Etienne; Pierre Joanne; Cyril Catelain; Stéphanie Riveron; Alexandra Clarissa Bayer; Jérémy Lafable; Isabel Punzon; Stéphane Blot; Onnik Agbulut; Jean-Thomas Vilquin
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-03-10       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.